Injection site bruising: FDA reporting patterns
77,816 FDA FAERS reports mention Injection site bruising. 12,818 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 13,774 reports
- Adalimumab: 11,046 reports
- Dupilumab: 5,525 reports
- Teriparatide: 4,758 reports
- Evolocumab: 4,724 reports
- Tirzepatide: 3,468 reports
- Exenatide: 3,145 reports
- Interferon Beta-1a: 2,555 reports
- Secukinumab: 1,996 reports
- Dulaglutide: 1,883 reports
- Corticotropin: 1,433 reports
- Glatiramer: 1,308 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.